23 Sep 2025 | 5 Mins Read
Pharma stock jumps on EMA approval for new rivaroxaban drug.
Flipitmoney
Shares of Shilpa Medicare Limited hit a 5 percent upper circuit, after EMA granted initial authorisation for medicinal products in Europe, unlocking a $2.5 billion market opportunity. With a market cap of Rs. 8,025 crores, the shares of Shilpa Medicare Limited hit a 5 percent upper circuit at Rs. 858.1 on BSE, as against its previous closing price of Rs. 817.25.